• 1. The First Clinical Medical College of Lanzhou University, Lanzhou, 730000, P.R.China;
  • 2. Department of ICU, The First Hospital of Lanzhou University, Lanzhou, 730000, P.R.China;
  • 3. Evidence-based Medicine Center, Lanzhou University, Lanzhou, 730000, P.R.China;
LIU Jian, Email: medecinliu@sina.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate the effect of fast track surgery (FTS) after esophageal cancer surgery. Methods  The randomized controlled trial (RCT) and observational studies about FTS for esophageal cancer in PubMed、EMbase、The Cochrane Library、Web of Science、CBM、CNKI and WanFang databases were searched up to May 2017. Then the studies were screened according to the inclusion and exclusion criteria by two researchers. Data were analyzed by Stata12.0 software. Results  Totally 13 RCTs and 5 observational studies with 2 447 patients were eligible for analysis. Compared with the control group, incidence of postoperative complications (OR=0.53, 95%CI 0.40 to 0.71, P<0.05) significantly reduced in the FTS group, but there was no significant difference between the two groups in readmission rate (OR=1.21, 95%CI 0.83 to 1.76, P=0.313) and 30 d mortality rate (OR=0.72, 95%CI 0.43 to 1.20, P=0.207). Conclusion  FTS can safely and effectively accelerate the recovery of patients with esophageal cancer and it owns important clinical values.

Citation: LIU Jingjing, LU Jiaju, SHI Jiang, LIN Qingling, GUO Hong, TIAN Jinhui, LIU Jian, YANG Kehu. Application effect of fast track surgery for patients with esophageal cancer: A systematic review and meta-analysis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(7): 596-603. doi: 10.7507/1007-4848.201707005 Copy

  • Previous Article

    Shor-term effect of coronary artery bypass grafting by different ways for harvesting great saphenous vein
  • Next Article

    Recombinant human serum albumin promotes differentiation of human pluripotent stem cells into cardiomyocytes in vitro